Position in ARGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,853,584,218
+$1,208,881,641 QoQ
Shares Held
5,231,452
+4.8% QoQ
Ownership
8.41%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1
of 504 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,384 across 370 Biotechnology names. ARGX ranks #1 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
This page
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in ARGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,853,584,218 | 5,231,452 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,644,702,577 | 4,991,034 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,702,860,661 | 5,592,319 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,198,446,714 | 5,692,346 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,989,546,078 | 5,423,508 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,351,854,010 | 5,663,207 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,455,206,530 | 5,618,222 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,598,445,300 | 4,793,472 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,517,175,097 | 3,527,986 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,287,473,059 | 3,270,022 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,450,340,677 | 3,812,372 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,440,929,672 | 4,964,973 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,970,374,717 | 5,055,743 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,949,896,682 | 5,233,498 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $1,973,389,489 | 5,209,169 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,830,822,680 | 5,185,732 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,884,679,072 | 4,974,343 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,475,687,058 | 4,680,115 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,606,111,063 | 4,586,399 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,347,044,726 | 4,460,413 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $1,403,336,041 | 4,661,162 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,287,092,995 | 4,673,710 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,386,398,194 | 4,714,197 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $1,230,078,149 | 4,685,655 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,053,593,281 | 4,677,855 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $560,037,842 | 4,251,407 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||